cancer-therapy

Documents about cancer-therapy

• Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma#454033ClinicalTrials.gov
• Natural-Origin Compounds as Future Precision Partners in Combination Cancer Therapy#482729IBISS
• Treatment terminations during radiation therapy: A retrospective descriptive single-center analysis#258680PLOS
• Time to Personalize Surveillance for Cancer Therapy-Related Cardiac Dysfunction in HER2-Targeted Therapy: One Size Does Not Fit All.#395960NCBI PubMed Central
• Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma#633733ClinicalTrials.gov
• An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC)#290975ClinicalTrials.gov
• Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma#451527ClinicalTrials.gov
• Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adjuvant Treatment in Resectable Stage III Colorectal Cancer or Non-Small Cell Lung Cancer#683072ClinicalTrials.gov
• The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG)#174856ClinicalTrials.gov
• Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer#651245ClinicalTrials.gov
• Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer#800496ClinicalTrials.gov
• OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission#356523ClinicalTrials.gov
• Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer#154725ClinicalTrials.gov
• A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer#143581ClinicalTrials.gov
• Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder#152390ClinicalTrials.gov
• Overview of Cancer Treatment and The Role of Radiation Therapy in Cancer Management In Handbook of Common Cancers in Nigeria#313582University of Ibadan Institutional Repository
• LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer#325279ClinicalTrials.gov
• A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.#356463ClinicalTrials.gov
• Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma#366583ClinicalTrials.gov
• Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer#448255ClinicalTrials.gov
• Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension#668861ClinicalTrials.gov
• Reducing Acute Upper Gastrointestinal Side-Effects of Thoracic Irradiation#800267ClinicalTrials.gov
• Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma#208273ClinicalTrials.gov
• Foslip-Mediated Photodynamic Treatment Reprograms Macrophages Phenotype in Tri-Culture Head and Neck Cancer Spheroids#14235HAL (France)
• Covalently Anti-HER2-Functionalized MOF for Targeted Chemotherapy and NIR-Activated Photothermal/Photodynamic Cancer Therapy#279867Figshare
• Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention#356477ClinicalTrials.gov
• Cascade Therapy With Doxorubicin and Survivin-Targeted Tailored Nanoparticles: an Effective Alternative for Sensitization of Cancer Cells To Chemotherapy#681779İzmir Yüksek Teknoloji Enstitüsü
• Artificial intelligence-based screening of phytochemicals for targeted cancer therapy.#125380NCBI PubMed Central
• Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC)#162484ClinicalTrials.gov
• Analysis of intratumoural bacteria: Opportunities and challenges for cancer therapy.#224840NCBI PubMed Central
• Data Management and Sharing Plan for: STTR: Advancing Extracellular Vesicle Therapy for Brain Cancer#228850UNC Dataverse Dataverse OAI Archive
• Cancer therapy-induced ototoxicity: Current challenges and emerging management strategies.#269535NCBI PubMed Central
• Reversion mutations define minimal BRCA1/2 requirements for therapy resistance#303426bioRxiv / medRxiv
• Vaccine Therapy in Treating Patients With Metastatic Melanoma#366641ClinicalTrials.gov
• Alkylphosphocholine Analogs for Broad-Spectrum Cancer Imaging and Therapy#384074CiNii
• Turning Cold Tumors Into Hot Tumors: Implications for Cancer Therapy.#427686NCBI PubMed Central
• Application and prospects of fecal microbiota transplantation in cancer therapy.#457445NCBI PubMed Central
• Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia#463744ClinicalTrials.gov
• Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma#471501ClinicalTrials.gov
• Phase II Trial of Continuation Therapy in Advanced NSCLC#683088ClinicalTrials.gov
• Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations#256870ClinicalTrials.gov
• A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer#245489ClinicalTrials.gov
• Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer#287530ClinicalTrials.gov
• Exercise and sport medicine during chemo(radio)therapy in patients with pancreatic cancer#212001Research Online
• Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer (NSCLC) Stages IIIB/IV#283104ClinicalTrials.gov
• Longitudinal Multi-Omic Characterization of Patient Responses to Neoadjuvant HER2-Targeted Therapy#298185api.researchdata.se
• Advances in cancer immunotherapy: adoptive cell therapy and immune cell engagers in solid tumours#299165Springer Nature OA
• A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)#414386ClinicalTrials.gov
• Vaccine safety for individuals receiving immune checkpoint inhibitor therapy: A narrative review of current literature and recommendations for future research#4645Europe PMC
• Self-help cognitive behavioural therapy for hot flushes and night sweats during androgen deprivation therapy for prostate cancer: the MANCAN2 randomized controlled trial.#150002NCBI PubMed Central